论文信息 - Phase I study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC). - 字舞流文

Phase I study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC).

J. Berlin | M. Thomas | A. Santoro | Tae-You Kim | C. Denlinger | J. Williams | F. Braud | C. Gallo-Stampino | E. Wang | P. Zucali | M. Simonelli | C. Noberasco | M. Carpentieri | A. Brisendine | J. A. Williams